Studies Lessen Fear Of Using Prostate Drug: Tests Show It Cuts Risk Of Cancer, Improves Detection

September 20, 2007 – 3:13 am | posted in Public Health

A controversial drug that can prevent prostate cancer appears to be even more beneficial than previously thought. Two studies to be published in the Journal of the National Cancer Institute found the drug finasteride not only shrinks enlarged prostate glands and reduces the risk of prostate cancer but also improves detection of the most lethal tumors. Finasteride is one of only a handful of drugs that have actually been shown to prevent cancer. (Tamoxifen, which cuts breast cancer risk in half, is another.) But doctors have been reluctant to prescribe finasteride because it was believed to promote the growth of high-grade, or aggressive, tumors. A 2003 study published in the New England Journal of Medicine showed that m…

Also Read

  • Study Suggests Role For Y Chromosome In Prostate Cancer
  • Prostate cancer killed 140 N.H. men in 2006
  • New Prostate Cancer Technology Saving Lives
  • Largest PSA Bounce Study Eases Worry Of Prostate Cancer Returning
  • Statin Use Associated With Decreased Risk Of Advanced Prostate Cancer
  • Obesity, Diabetes, And Risk Of Prostate Cancer: Results From The Prostate Cancer Prevention Trial
  • African-Americans With Prostate Cancer More Likely To Have Family History Of Prostate, Breast Cancer
  • Prostate Cancer Awareness Week To Screen Thousands
  • Serum Tests As Precursor To Invasive Scope - Enabling Early Gastric Cancer Detection
  • D.C. Denies Prostate Cancer Vaccine, Provenge: Dendreon (WA) Not FDA To Blame
  • You must be logged in to post a comment.